Chinese billionaire Guo Guangchang’s Shanghai-based Fosun Pharmaceutical Group has approached several private equity firms to buy its stake in Hyderabd India-based Gland Pharma according to a report in Money Control Reportedly, Advent International, Baring Private Equity Asia, Bain Capital, Blackstone, Carlyle and KKR are among those who have been approached....
Recipharm to Acquire Major Stake in Indian Sterile Injectables CMO
Swedish contract development and manufacturing organization, Recipharm, plans to acquire 74 percent of shares of Nitin Lifesciences, an Indian sterile injectables contract manufacturing organization, for $105.2 million. The deal is expected to take place during Q1 2016, following approval from the Indian Foreign Investment Promotion Board, reports BioSpectrumAsia. On...